Implementing Precision Medicine Approaches to Guide Anti-platelet Selection

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT04090281

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04090281
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04090281. Allocation not applicable; no masking; primary purpose treatment. Start 2020-03-13 (actual); primary completion 2023-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Implementing Precision Medicine Approaches to Guide Anti-platelet Selection
Condition
Acute Coronary Syndrome (ACS)
Condition
STEMI - ST Elevation Myocardial Infarction (MI)
Condition
NSTEMI - Non-ST Segment Elevation MI
Condition
Unstable Angina (UA)
Intervention (Genetic)
CYP2C19 genotyping
Lead sponsor
University of Southern California (class: other)

Record details

Record id
cardio:ct-nct04090281
Content hash
a185359d24405de9052f35af294796cd321a52cb109582bc54588ade18a53ee3